MENU
ANEB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Anebulo Pharmaceuticals (ANEB) Ownership - Who owns Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals Inc is a clinical-stage biotechnology company, developing novel solutions for people suffering from cannabinoid overdose and substance addiction... Show more
Profile
Industry
N/A
Address
1017 Ranch Road 620 South
Phone
+1 512 598-0931
Employees
2
Web
https://www.anebulo.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
98.9M
P/E Ratio
N/A
Total Cash
13.28M
Projected Growth
N/A
Total Debt
N/A
Revenue
N/A
Risk (Beta)
-0.22
Dividend Yield
N/A
Total Cash/Share
0.32
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
ANEB
Capitalization
98.9M
P/E Ratio
N/A
Risk (Beta)
-0.22
Dividend Yield
N/A
Total Cash
13.3M
Total Cash/Share
0.32
Total Debt
N/A
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
13.5M
P/B Ratio
7.35
Cash Flow
N/A
Earnings
-0.25
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
41.1K
Current Ratio
25.29
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-7.27M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-76.88
Shares Held By Institutions
30M
Shares Outstanding - Current
41.1M
Total Liabilities
546K
Total Volume MTD
N/A
Value
N/A
Gain YTD
43.292
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ANEB showed earnings on May 13, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
1017 Ranch Road 620 South
Phone
+1 512 598-0931
Employees
2
Web
https://www.anebulo.com